SCM
ANRO icon

Sterling Capital Management’s Alto Neuroscience ANRO Stock Holding History

Sterling Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43K Buy
+92
New +$2.13K ﹤0.01% 2942
2025
Q2 		– Sell
-161
Closed -$348 – 3417
2025
Q1 		$348 Sell
161
-141
-47% -$505 ﹤0.01% 3015
2024
Q4 		$1.28K Buy
302
+261
+637% +$1.63K ﹤0.01% 2892
2024
Q3 		$469 Buy
+41
New +$502 ﹤0.01% 2903

Other funds holding ANRO

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sterling Capital Management's ANRO Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 92 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #2942 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in ANRO as recently as Q1 2025.

Sterling Capital Management first reported a position in ANRO in Q3 2024 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Sterling Capital Management held 92 shares of Alto Neuroscience worth $2.43K as of Q2 2026.
  • Alto Neuroscience was a new Sterling Capital Management position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2942 holding.
  • Sterling Capital Management first reported a position in Alto Neuroscience in Q3 2024 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.